Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (141-150 of 418) with videos related to

Pageof 42
Sort By:
American Journal of Clinical Dermatology|March 25, 2020
Malignancy Rates in Brodalumab Clinical Studies for PsoriasisAlice Gottlieb, Mark Lebwohl, Clive Liu, et al.
Journal of Drugs in Dermatology : JDD|April 10, 2020
Recapture Rate of Brodalumab in Patients With a Lapse in TreatmentMark Lebwohl, Jennifer Cather, April Armstrong, et al.
International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.
Journal of the American Academy of Dermatology|April 12, 2024
Narrowband ultraviolet B light phototherapy: A consensus on standards of careElisabeth Richard, Elizabeth Buzney, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|March 15, 2003
Mammographic findings in pseudoxanthoma elasticumLionel Bercovitch, Barbara Schepps, Susan Koelliker, et al.
The Journal of Clinical and Aesthetic Dermatology|March 21, 2022
Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM StudyUlrich Mrowietz, Leon Kircik, Kristian Reich, et al.
Cutis|February 12, 2015
Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosisShelbi C Jim On, Madelaine Haddican, Alex Yaroshinsky, et al.
Cutis|April 7, 2015
Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveysEmily Edson-Heredia, Baojin Zhu, Jiaying Guo, et al.
Journal of Cutaneous Medicine and Surgery|April 27, 2002
Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapiesCarin H Endzweig-Gribetz, Christopher Brady, Charles Lynde, et al.
Kidney Medicine|March 30, 2026
Three People With Recurrent Nephrolithiasis and Heterozygous <i>ABCC6</i> MutationsDouglas Farrell, Jaime Uribarri, Tessa R Pitman, et al.
Pageof 42

Showing results (141-150 of 418) with videos related to

Sort By:
Pageof 42
American Journal of Clinical Dermatology|March 25, 2020
Malignancy Rates in Brodalumab Clinical Studies for PsoriasisAlice Gottlieb, Mark Lebwohl, Clive Liu, et al.
Journal of Drugs in Dermatology : JDD|April 10, 2020
Recapture Rate of Brodalumab in Patients With a Lapse in TreatmentMark Lebwohl, Jennifer Cather, April Armstrong, et al.
International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.
Journal of the American Academy of Dermatology|April 12, 2024
Narrowband ultraviolet B light phototherapy: A consensus on standards of careElisabeth Richard, Elizabeth Buzney, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|March 15, 2003
Mammographic findings in pseudoxanthoma elasticumLionel Bercovitch, Barbara Schepps, Susan Koelliker, et al.
The Journal of Clinical and Aesthetic Dermatology|March 21, 2022
Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM StudyUlrich Mrowietz, Leon Kircik, Kristian Reich, et al.
Cutis|February 12, 2015
Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosisShelbi C Jim On, Madelaine Haddican, Alex Yaroshinsky, et al.
Cutis|April 7, 2015
Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveysEmily Edson-Heredia, Baojin Zhu, Jiaying Guo, et al.
Journal of Cutaneous Medicine and Surgery|April 27, 2002
Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapiesCarin H Endzweig-Gribetz, Christopher Brady, Charles Lynde, et al.
Kidney Medicine|March 30, 2026
Three People With Recurrent Nephrolithiasis and Heterozygous <i>ABCC6</i> MutationsDouglas Farrell, Jaime Uribarri, Tessa R Pitman, et al.
Pageof 42